Company profile for Nippon Chemiphar

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Since 2000, Nippon Chemiphar has promoted a basic management strategy based on three goals: establishing a strong presence in the generics business; becoming a leader in the field of alkalization therapy; and pursuing in-house drug discovery and development. As initiatives designed to attain these three goals, first, we are currently striving to increase our earnings capacity by the generic drugs business. Second, we continue...
Since 2000, Nippon Chemiphar has promoted a basic management strategy based on three goals: establishing a strong presence in the generics business; becoming a leader in the field of alkalization therapy; and pursuing in-house drug discovery and development. As initiatives designed to attain these three goals, first, we are currently striving to increase our earnings capacity by the generic drugs business. Second, we continue to conduct clinical research and pursue educational activities to become a frontrunner in the field of alkalization therapy, a remedial treatment.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
2-2-3, Iwamoto-cho, Chiyoda-ku, Tokyo 101-0032
Telephone
Telephone
81 + 3-3863-1211
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.business-standard.com/article/companies/sun-pharmaceutical-bullish-on-japanese-market-as-peers-lose-interest-119111100012_1.html

S. Das BUSINESS STANDARD
11 Nov 2019

http://www.prnewswire.com/news-releases/nippon-chemiphar-and-som-biotech-to-cooperate-on-new-orphan-disease-indications-for-bevantolol-calvan-650402403.html

PR NEWSWIRE
11 Oct 2017

ABOUT THIS PAGE

Contact Nippon Chemiphar and get a quotation

Nippon Chemiphar is a supplier offers 2 products (APIs, Excipients or Intermediates).

Find a price of NP-0730-PP DRUG SUBSTANCE bulk with DMF offered by Nippon Chemiphar

Find a price of 2-Oxiranecarboxylic Acid Sodium Salt bulk offered by Nippon Chemiphar

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty